NCOA3 and breast carcinoma: Loss of miR-17 and miR-20b confers Taxol resistance in breast cancer by enhancing expression of nuclear receptor coactivator 3 (NCOA3) [112], which is significantly upregulated in Taxol-resistant breast cancer cells.